Europe Cancer Tissue Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Cancer Tissue Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Cancer Tissue Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Cancer Tissue Diagnostics Market Regional Analysis

6.2 Europe Cancer Tissue Diagnostics Market Revenue 2016-2027 (US$ Million)

6.3 Europe Cancer Tissue Diagnostics Market Forecast Analysis

7. Europe Cancer Tissue Diagnostics Market Analysis – by Test Type

7.1 Immunohistochemical Tests and In Situ Hybridization Tests

7.1.1 Overview
7.1.2 Immunohistochemical Tests and In Situ Hybridization Tests: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Europe Cancer Tissue Diagnostics Market – Europe Analysis

8.1 Overview

8.2 Europe

8.2.1 Europe Cancer Tissue Diagnostics Market Breakdown, by Key Country, 2019 and 2027 (%)
8.2.1.1 Europe Cancer Tissue Diagnostics Market – Revenue and Forecast Analysis – by Country
8.2.1.1 UK: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.1.1 UK: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

8.2.1.2 Germany: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.2.1 Germany: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

8.2.1.3 France: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.3.1 France: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

8.2.1.4 Russia: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.4.1 Russia: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

8.2.1.5 Italy: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.5.1 Italy: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

8.2.1.6 Rest of Europe: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.2.1.6.1 Rest of Europe: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type

9. Competitive Landscape

9.1 Heat Map Analysis

9.2 Company Positioning and Concentration

10. Industry Landscape

10.1 Overview

10.2 Market Initiative

10.3 Partnerships and Collaborations

10.4 Other Developments

11. Company Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments

11.2 Thermo Fisher Scientific Inc.

11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments

11.3 Bio Rad Laboratories Inc.

11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments

11.4 Abbott

11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

11.5 Enzo Life Sciences, Inc.

11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

11.6 Agilent Technologies, Inc.

11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments

11.7 Cancer Genetics Inc.

11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments

11.8 Merck KGaA (Sigma-Aldrich Co. LLC)

11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments

11.9 Danaher

11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

11.10 Abcam plc.

11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix

12.1 About Business Market Insights

12.2 List of Abbreviations

Europe Cancer Tissue Diagnostics Market

Analysis and Forecasts by Test Type (Immunohistochemical Tests and In Situ Hybridization Tests), and Country